IN

INVITES BIOCORE CO., LTD

A CRO advancing precision medicine via genomic analysis and clinical trial support services.

216400 | KO

Overview

Corporate Details

ISIN(s):
KR7216400002
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로9길 33, 금천구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Invites Biocore Co., Ltd. is a biotechnology company and Contract Research Organization (CRO) established in 2001. The company specializes in supporting new drug development and advancing precision medicine. Its core services include bioanalytical testing, central lab services, clinical trial support, and genetic and cell screening, with a focus on individual genomic analysis. By leveraging advanced technology, Invites Biocore partners with domestic and international pharmaceutical companies, research institutes, and medical institutions to facilitate personalized healthcare and support the data-based bio healthcare industry throughout the R&D lifecycle.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-04 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 91.6 KB
2025-06-17 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-05-21 00:00
Regulatory News Service
조회공시요구(풍문또는보도) (영업활동의 일부정지)
Korean 3.4 KB
2025-05-21 00:00
Regulatory News Service
주권매매거래정지 (풍문 또는 보도 관련)
Korean 5.0 KB
2025-05-21 00:00
Regulatory News Service
조회공시요구(풍문또는보도)에대한답변(부인)
Korean 5.4 KB
2025-05-21 00:00
Delisting Announcement
주권매매거래정지해제 (풍문 등 조회결과 공시)
Korean 4.3 KB
2025-04-30 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정 (중간배당)
Korean 19.0 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.7 KB
2025-03-26 00:00
Board/Management Information
대표이사변경
Korean 10.1 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 15.5 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.1 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 200.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 170.3 KB

Automate Your Workflow. Get a real-time feed of all INVITES BIOCORE CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INVITES BIOCORE CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INVITES BIOCORE CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ECHOMARKETING Co.,Ltd. Logo
Global agency accelerating sales with data-driven, full-funnel digital marketing.
South Korea
230360
Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland
EEZY
Elicio Therapeutics, Inc. Logo
Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.
United States of America
ELTX
enCore Energy Corp. Logo
American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.
United States of America
EU
ENERGY FUELS INC Logo
A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.
United States of America
UUUU
ENIGMATIG LTD Logo
Global expansion and regulatory compliance consultancy for the financial services industry.
United States of America
EGG
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan
7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610
Enveric Biosciences, Inc. Logo
Develops novel neuroplastogen drugs for severe mental health and addiction disorders.
United States of America
ENVB
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050

Talk to a Data Expert

Have a question? We'll get back to you promptly.